{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T22:09:32Z","timestamp":1774303772239,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003035","name":"Aase og Ejnar Danielsens Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016545","name":"Roche Diagnostics Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009898","name":"Beckett-Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009898","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007438","name":"Familien Hede Nielsens Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009418","name":"Nordsj\u00e6llands Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009418","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008249","name":"Frimodt-Heineke Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008249","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.vaccine.2026.128194","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T19:10:16Z","timestamp":1767726616000},"page":"128194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Spike antibody levels and risk of SARS-CoV-2 reinfection: a two-year cohort study in previously infected adults"],"prefix":"10.1016","volume":"74","author":[{"given":"Elias Frost","family":"Wiwe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisbeth","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nessrin","family":"Talouzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casper","family":"Roed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zitta Barrella","family":"Harboe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thea K\u00f8lsen","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Bae Lee","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thore","family":"Hillig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128194_bb0005","first-page":"1","article-title":"The hospital and mortality burden of COVID-19 compared with influenza in Denmark: a national observational cohort study, 2022\u201324","volume":"3099","author":"Bager","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128194_bb0015","series-title":"European Centre for Disease Prevention and Control. Considerations for the use of antibody tests for SARS-COV-2 -first update","year":"2022"},{"key":"10.1016\/j.vaccine.2026.128194_bb0020","doi-asserted-by":"crossref","DOI":"10.1093\/jalm\/jfab173","article-title":"Long-term comparison of 7 SARS-CoV-2 antibody assays in the North Zealand Covid-19 cohort","author":"Wiwe","year":"2022","journal-title":"J Appl Lab Med"},{"key":"10.1016\/j.vaccine.2026.128194_bb0025","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1403494810387965","article-title":"The Danish civil registration system","volume":"39","author":"Pedersen","year":"2011","journal-title":"Scand J Public Health"},{"key":"10.1016\/j.vaccine.2026.128194_bb0030","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.vaccine.2026.128194_bb0035","doi-asserted-by":"crossref","unstructured":"Voldstedlund M, Haarh M, M\u00f8lbak K. The Danish Microbiology Database (MiBa) 2010 to 2013. Euro Surveill 2014;19. Doi: https:\/\/doi.org\/10.2807\/1560-7917.es2014.19.1.20667.","DOI":"10.2807\/1560-7917.ES2014.19.1.20667"},{"key":"10.1016\/j.vaccine.2026.128194_bb0040","first-page":"17","article-title":"The Danish vaccination register","author":"Grove Krause","year":"2012","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2026.128194_bb0050","doi-asserted-by":"crossref","first-page":"E151","DOI":"10.1515\/cclm-2022-0082","article-title":"Misleading nomenclature of units of WHO materials used for standardization of SARS COv-2 serology","volume":"60","author":"Hansen","year":"2022","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.vaccine.2026.128194_bb0055","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cmi.2020.11.028","article-title":"Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity","volume":"27","author":"Yahav","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2026.128194_bb0060","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries","volume":"173","author":"Quan","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"375","key":"10.1016\/j.vaccine.2026.128194_bb0065","first-page":"43","article-title":"Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial","volume":"2022","author":"Gilbert","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2026.128194_bb0070","doi-asserted-by":"crossref","first-page":"e309","DOI":"10.1016\/S2666-5247(23)00012-5","article-title":"Correlates of protection against COVID-19 infection and intensity of symptomatic disease in vaccinated individuals exposed to SARS-CoV-2 in households in Israel (ICoFS): a prospective cohort study","volume":"4","author":"Regev-Yochay","year":"2023","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.vaccine.2026.128194_bb0075","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.vaccine.2021.12.006","article-title":"Towards a population-based threshold of protection for COVID-19 vaccines","volume":"40","author":"Goldblatt","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128194_bb0080","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/s41591-021-01540-1","article-title":"Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection","volume":"27","author":"Feng","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2026.128194_bb0085","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s40121-024-01090-2","article-title":"SARS-CoV-2 SPIKE antibody levels can indicate Immuno-resilience to re-infection: a real-world study","volume":"14","author":"Jin","year":"2025","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.vaccine.2026.128194_bb0090","first-page":"7","article-title":"SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay","author":"Peluso","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.vaccine.2026.128194_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JCM.01231-21","article-title":"Sars-cov-2 serologic assays dependent on dual-antigen binding demonstrate diverging kinetics relative to other antibody detection methods","volume":"59","author":"Theel","year":"2021","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2026.128194_bb0100","first-page":"10","article-title":"One-year follow-up of COVID-19 patients indicates substantial assay-dependent differences in the kinetics of SARS-CoV-2 antibodies","author":"Egger","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.vaccine.2026.128194_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciimmunol.ade2798","article-title":"Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination","volume":"8","author":"Irrgang","year":"2023","journal-title":"Sci Immunol"},{"key":"10.1016\/j.vaccine.2026.128194_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpubh.2021.716421","article-title":"Is my cough a cold or Covid? A qualitative study of COVID-19 symptom recognition and attitudes toward testing in the UK","volume":"9","author":"Mowbray","year":"2021","journal-title":"Front Public Health"},{"key":"10.1016\/j.vaccine.2026.128194_bb0115","first-page":"14","article-title":"Drivers of SARS-CoV-2 testing behaviour: a modelling study using nationwide testing data in England","author":"Kim","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2026.128194_bb0120","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1136\/oemed-2022-108713","article-title":"Occupational risk of SARS-CoV-2 infection: a nationwide register-based study of the Danish workforce during the COVID-19 pandemic, 2020-2021","volume":"80","author":"Bonde","year":"2023","journal-title":"Occup Environ Med"},{"key":"10.1016\/j.vaccine.2026.128194_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/ash.2024.485","article-title":"Association between social activities and risk of COVID-19 in a cohort of healthcare personnel","volume":"5","author":"Shoemaker","year":"2025","journal-title":"Antimicrobial Stewardship and Healthcare Epidemiology"},{"key":"10.1016\/j.vaccine.2026.128194_bb0130","first-page":"371","article-title":"Inferring the effectiveness of government interventions against COVID-19","volume":"2021","author":"Brauner","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2026.128194_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0270260","article-title":"Impact of COVID-19 on the social relationships and mental health of older adults living alone: a two-year prospective cohort study","volume":"17","author":"Ryu","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2026.128194_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112308","article-title":"The changing health impact of vaccines in the COVID-19 pandemic: a modeling study","volume":"42","author":"Cohen","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.vaccine.2026.128194_bb0145","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S1473-3099(24)00220-2","article-title":"Relative vaccine protection, disease severity, and symptoms associated with the SARS-CoV-2 omicron subvariant BA.2.86 and descendant JN.1 in Denmark: a nationwide observational study","volume":"24","author":"Moustsen-Helms","year":"2024","journal-title":"Lancet Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26000010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26000010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T23:53:01Z","timestamp":1773964381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26000010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":27,"alternative-id":["S0264410X26000010"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128194","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spike antibody levels and risk of SARS-CoV-2 reinfection: a two-year cohort study in previously infected adults","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128194","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128194"}}